Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

INNOVIVA, INC. (INVA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

INNOVIVA, INC. (INVA), most recent 12 months reported: revenue $440M, net income $357.24M, free cash flow $189.44M. Latest balance sheet on file: liquid cash $579.06M, total debt $258.45M, net cash $320.6M. From SEC filings. Others in Pharmaceutical Preparations: ORGANOGENESIS HOLDINGS INC. · LIQUIDIA CORPORATION · ARDELYX, INC. · ZAI LAB LIMITED · MANNKIND CORP · IRONWOOD PHARMACEUTICALS, INC. · SINOVAC BIOTECH LTD · XERIS BIOPHARMA HOLDINGS, INC.

Stock screener

Watchlist